Literature DB >> 33068247

Indexed left ventricular mass to QRS voltage ratio is associated with heart failure hospitalizations in patients with cardiac amyloidosis.

Jeremy A Slivnick1, Alexander L Wallner1, Ajay Vallakati1, Vien T Truong2, Wojciech Mazur2, Mohamed B Elamin3, Matthew S Tong1, Subha V Raman4, Karolina M Zareba5.   

Abstract

In cardiac amyloidosis (CA), amyloid infiltration results in increased left ventricular (LV) mass disproportionate to electrocardiographic (EKG) voltage. We assessed the relationship between LV mass-voltage ratio with subsequent heart failure hospitalization (HHF) and mortality in CA. Patients with confirmed CA and comprehensive cardiovascular magnetic resonance (CMR) and EKG exams were included. CMR-derived LV mass was indexed to body surface area. EKG voltage was assessed using Sokolow, Cornell, and Limb-voltage criteria. The optimal LV mass-voltage ratio for predicting outcomes was determined using receiver operating characteristic curve analysis. The relationship between LV mass-voltage ratio and HHF was assessed using Cox proportional hazards analysis adjusting for significant covariates. A total of 85 patients (mean 69 ± 11 years, 22% female) were included, 42 with transthyretin and 43 with light chain CA. At a median of 3.4-year follow-up, 49% of patients experienced HHF and 60% had died. In unadjusted analysis, Cornell LV mass-voltage ratio was significantly associated with HHF (HR, 1.05; 95% CI 1.02-1.09, p = 0.001) and mortality (HR, 1.05; 95% CI 1.02-1.07, p = 0.001). Using ROC curve analysis, the optimal cutoff value for Cornell LV mass-voltage ratio to predict HHF was 6.7 gm/m2/mV. After adjusting for age, NYHA class, BNP, ECV, and LVEF, a Cornell LV mass-voltage ratio > 6.7 gm/m2/mV was significantly associated with HHF (HR 2.25, 95% CI 1.09-4.61; p = 0.03) but not mortality. Indexed LV mass-voltage ratio is associated with subsequent HHF and may be a useful prognostic marker in cardiac amyloidosis.

Entities:  

Keywords:  Cardiac MRI; Cardiac amyloidosis; Cardiomyopathy; Electrocardiography; Heart failure

Mesh:

Year:  2020        PMID: 33068247      PMCID: PMC7969486          DOI: 10.1007/s10554-020-02059-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

Review 1.  Assessment of left ventricular mass by cardiovascular magnetic resonance.

Authors:  Saul G Myerson; Nicholas G Bellenger; Dudley J Pennell
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

2.  On the value of geometry-based models for left ventricular volumetry in magnetic resonance imaging and electron beam tomography: a Bland-Altman analysis.

Authors:  Gert Reiter; Ursula Reiter; Rainer Rienmüller; Nina Gagarina; Alexander Ryabikin
Journal:  Eur J Radiol       Date:  2004-11       Impact factor: 3.528

3.  The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

Authors:  Neil J Perkins; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2006-01-12       Impact factor: 4.897

4.  Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.

Authors:  P M Okin; M J Roman; R B Devereux; T G Pickering; J S Borer; P Kligfield
Journal:  Hypertension       Date:  1998-04       Impact factor: 10.190

5.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

6.  Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.

Authors:  J D Carroll; W H Gaasch; K P McAdam
Journal:  Am J Cardiol       Date:  1982-01       Impact factor: 2.778

Review 7.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Authors:  James C Moon; Daniel R Messroghli; Peter Kellman; Stefan K Piechnik; Matthew D Robson; Martin Ugander; Peter D Gatehouse; Andrew E Arai; Matthias G Friedrich; Stefan Neubauer; Jeanette Schulz-Menger; Erik B Schelbert
Journal:  J Cardiovasc Magn Reson       Date:  2013-10-14       Impact factor: 5.364

8.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Adam Castaño; David L Narotsky; Nadira Hamid; Omar K Khalique; Rachelle Morgenstern; Albert DeLuca; Jonah Rubin; Codruta Chiuzan; Tamim Nazif; Torsten Vahl; Isaac George; Susheel Kodali; Martin B Leon; Rebecca Hahn; Sabahat Bokhari; Mathew S Maurer
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

9.  Magnetic Resonance in Transthyretin Cardiac Amyloidosis.

Authors:  Ana Martinez-Naharro; Thomas A Treibel; Amna Abdel-Gadir; Heerajnarain Bulluck; Giulia Zumbo; Daniel S Knight; Tushar Kotecha; Rohin Francis; David F Hutt; Tamer Rezk; Stefania Rosmini; Candida C Quarta; Carol J Whelan; Peter Kellman; Julian D Gillmore; James C Moon; Philip N Hawkins; Marianna Fontana
Journal:  J Am Coll Cardiol       Date:  2017-07-25       Impact factor: 24.094

10.  Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.

Authors:  Thomas A Treibel; Marianna Fontana; Janet A Gilbertson; Silvia Castelletti; Steven K White; Paul R Scully; Neil Roberts; David F Hutt; Dorota M Rowczenio; Carol J Whelan; Michael A Ashworth; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2016-08       Impact factor: 7.792

View more
  2 in total

Review 1.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

2.  Left ventricular mass index-to-QRS-voltage ratio predicts outcomes in heart failure with preserved ejection fraction.

Authors:  Yoshiharu Kinugasa; Kensuke Nakamura; Hiroko Kamitani; Masayuki Hirai; Kiyotaka Yanagihara; Masahiko Kato; Toshiyuki Nagai; Tsutomu Yoshikawa; Yoshihiko Saito; Yasuchika Takeishi; Kazuhiro Yamamoto; Toshihisa Anzai
Journal:  ESC Heart Fail       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.